Albiglutide
Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
GSK · Phase 1 · Completed · Enrollment 34
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| GSK716155 | T2D only | n/r | n/r | n/r | n/r |
| placebo | T2D only | n/r | n/r | n/r | n/r |